Advertisement

Determinants of Discrepancies in Detection and Comparison of the Prognostic Significance of Left Ventricular Hypertrophy by Electrocardiogram and Cardiac Magnetic Resonance Imaging

Published:November 29, 2014DOI:https://doi.org/10.1016/j.amjcard.2014.11.037
      Despite the low sensitivity of the electrocardiogram (ECG) in detecting left ventricular hypertrophy (LVH), ECG-LVH is known to be a strong predictor of cardiovascular risk. Understanding reasons for the discrepancies in detection of LVH by ECG versus imaging could help improve the diagnostic ability of ECG. We examined factors associated with false-positive and false-negative ECG-LVH, using cardiac magnetic resonance imaging (MRI) as the gold standard. We also compared the prognostic significance of ECG-LVH and MRI-LVH as predictors of cardiovascular events. This analysis included 4,748 participants (mean age 61.9 years, 53.5% females, 61.7% nonwhites). Logistic regression with stepwise selection was used to identify factors associated with false-positive (n = 208) and false-negative (n = 387), compared with true-positive (n = 208) and true-negative (n = 4,041) ECG-LVH, respectively. A false-negative ECG-LVH status was associated with increased odds of Hispanic race/ethnicity, current smoking, hypertension, increased systolic blood pressure, prolongation of QRS duration, and higher body mass index and with lower odds of increased ejection fraction (model-generalized R2 = 0.20). A false-positive ECG-LVH status was associated with lower odds of black race, Hispanic race/ethnicity, minor ST-T abnormalities, increased systolic blood pressure, and presence of any major electrocardiographic abnormalities (model-generalized R2 = 0.29). Both ECG-LVH and MRI-LVH were associated with an increased risk of cardiovascular disease events (hazard ratio 1.51, 95% confidence interval 1.03 to 2.20 and hazard ratio 1.81, 95% confidence interval 1.33 to 2.46, respectively). In conclusion, discrepancy in LVH detection by ECG and MRI can be relatively improved by considering certain participant characteristics. Discrepancy in diagnostic performance, yet agreement on predictive ability, suggests that LVH by ECG and LVH by imaging are likely to be two distinct but somehow related phenotypes.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Pewsner D.
        • Jüni P.
        • Egger M.
        • Battaglia M.
        • Sundström J.
        • Bachmann L.M.
        Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review.
        BMJ. 2007; 335: 711-719
        • Hancock E.W.
        • Deal B.J.
        • Mirvis D.M.
        • Okin P.
        • Kligfield P.
        • Gettes L.S.
        • Bailey J.J.
        • Childers R.
        • Gorgels A.
        • Josephson M.
        • Kors J.A.
        • Macfarlane P.
        • Mason J.W.
        • Pahlm O.
        • Rautaharju P.M.
        • Surawicz B.
        • van Herpen G.
        • Wagner G.S.
        • Wellens H.
        • American Heart Association Electrocardiography and Arrhythmias Committee
        • Council on Clinical Cardiology
        • American College of Cardiology Foundation
        • Heart Rhythm Society
        AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology.
        J Am Coll Cardiol. 2009; 53: 992-1002
        • Jain A.
        • Tandri H.
        • Dalal D.
        • Soliman E.Z.
        • Prineas R.J.
        • Folsom A.R.
        • Lima J.A.
        • Bluemke D.A.
        Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA).
        Am Heart J. 2010; 159: 652-658
        • Kannel W.B.
        • Gordon T.
        • Castelli W.P.
        • Margolis J.R.
        Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: the Framingham Study.
        Ann Intern Med. 1970; 72: 813-822
        • Rautaharju P.M.
        • LaCroix A.Z.
        • Savage D.D.
        • Haynes S.G.
        • Madans J.H.
        • Wolf H.K.
        • Hadden W.
        • Keller J.
        • Cornoni-Huntley J.
        Electrocardiographic estimate of left ventricular mass versus radiographic cardiac size and the risk of cardiovascular disease mortality in the epidemiological follow-up study of the first National Health and Nutrition Examination Survey.
        Am J Cardiol. 1988; 62: 59-66
        • Chrispin J.
        • Jain A.
        • Soliman E.Z.
        • Guallar E.
        • Alonso A.
        • Heckbert S.R.
        • Bluemke D.A.
        • Lima J.A.
        • Nazarian S.
        Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis).
        J Am Coll Cardiol. 2014; 63: 2007-2013
        • Havranek E.P.
        • Froshaug D.B.
        • Emserman C.D.
        • Hanratty R.
        • Krantz M.J.
        • Masoudi F.A.
        • Dickinson L.M.
        • Steiner J.F.
        Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity.
        Am J Med. 2008; 121: 870-875
        • Havranek E.P.
        • Emsermann C.D.
        • Froshaug D.N.
        • Masoudi F.A.
        • Krantz M.J.
        • Hanratty R.
        • Estacio R.O.
        • Dickinson L.M.
        • Steiner J.F.
        Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiography.
        J Electrocardiol. 2008; 41: 342-350
        • Bild D.E.
        • Bluemke D.A.
        • Burke G.L.
        • Bild D.E.
        • Bluemke D.A.
        • Burke G.L.
        Multi-ethnic study of atherosclerosis: objectives and design.
        Am J Epidemiol. 2002; 156: 871-881
        • Natori S.
        • Lai S.
        • Finn J.P.
        • Gomes A.S.
        • Hundley W.G.
        • Jerosch-Herold M.
        • Pearson G.
        • Sinha S.
        • Arai A.
        • Lima J.A.
        • Bluemke D.A.
        Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity.
        Am J Roentgenol. 2006; 186: S357-S365
        • Bluemke D.A.
        • Kronmal R.A.
        • Lima J.A.
        • Liu K.
        • Olson J.
        • Burke G.L.
        • Folsom A.R.
        The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study.
        J Am Coll Cardiol. 2008; 52: 2148-2155
        • Prineas R.J.
        • Crow R.
        • Blackburn H.W.
        The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification.
        J. Wright, Boston, MA1982: 203-229
        • Sokolow M.
        • Lyon T.P.
        The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. 1949.
        Ann Noninvasive Electrocardiol. 2001; 6: 343-368
        • Devereux R.B.
        • Casale P.N.
        • Eisenberg R.R.
        • Miller D.H.
        • Kligfield P.
        Electrocardiographic detection of left ventricular hypertrophy using echocardiographic determination of left ventricular mass as the reference standard. Comparison of standard criteria, computer diagnosis and physician interpretation.
        J Am Coll Cardiol. 1984; 3: 82-87
        • Bacharova L.
        • Estes E.H.
        • Bang L.E.
        • Hill J.A.
        • Macfarlane P.W.
        • Rowlandson I.
        • Schillaci G.
        Second statement of the Working Group on Electrocardiographic Diagnosis of Left Ventricular Hypertrophy.
        J Electrocardiol. 2011; 44: 568-570
        • Mayosi B.M.
        • Avery P.J.
        • Farrall M.
        • Keavney B.
        • Watkins H.
        Genome-wide linkage analysis of electrocardiographic and echocardiographic left ventricular hypertrophy in families with hypertension.
        Eur Heart J. 2008; 29: 525-530
        • Levy D.
        • Labib S.B.
        • Anderson K.M.
        • Christiansen J.C.
        • Kannel W.B.
        • Castelli W.P.
        Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy.
        Circulation. 1990; 81: 815-820
        • Kannel W.B.
        Left ventricular hypertrophy as a risk factor in arterial hypertension.
        Eur Heart J. 1992; 13: 82-88
        • Savage D.D.
        • Drayer J.I.
        • Henry W.L.
        • Savage D.D.
        • Drayer J.I.
        • Henry W.L.
        Echocardiographic assessment of cardiac anatomy and function in hypertensive patients.
        Circulation. 1979; 59: 623-632
        • Weber K.T.
        • Brilla C.G.
        Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.
        Circulation. 1991; 83: 1849-1865
        • Hein S.
        • Arnon E.
        • Kostin S.
        • Schönburg M.
        • Elsässer A.
        • Polyakova V.
        • Bauer E.P.
        • Klövekorn W.P.
        • Schaper J.
        Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms.
        Circulation. 2003; 107: 984-991
        • Rudolph A.
        • Abdel-Aty H.
        • Bohl S.
        • Boyé P.
        • Zagrosek A.
        • Dietz R.
        • Schulz-Menger J.
        Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
        J Am Coll Cardiol. 2009; 53: 284-291
        • McIntyre H.
        • Fry C.H.
        Abnormal action potential conduction in isolated human hypertrophied left ventricular myocardium.
        J Cardiovasc Electrophysiol. 1997; 8: 887-894
        • Cooklin M.
        • Wallis W.R.
        • Sheridan D.J.
        • Fry C.H.
        Conduction velocity and gap junction resistance in hypertrophied, hypoxic guinea-pig left ventricular myocardium.
        Exp Physiol. 1998; 83: 763-770
        • Bacharova L.
        • Szathmary V.
        • Kovalcik M.
        • Mateasik A.
        Effect of changes in left ventricular anatomy and conduction velocity on the QRS voltage and morphology in left ventricular hypertrophy: a model study.
        J Electrocardiol. 2010; 43: 200-220
        • Bacharova L.
        • Szathmary V.
        • Mateasik A.
        QRS complex and ST segment manifestations of ventricular ischemia: the effect of regional slowing of ventricular activation.
        J Electrocardiol. 2013; 46: 497-504
        • Dahlöf B.
        • Devereux R.
        • de Faire U.
        • Fyhrquist F.
        • Hedner T.
        • Ibsen H.
        • Julius S.
        • Kjeldsen S.
        • Kristianson K.
        • Lederballe-Pedersen O.
        • Lindholm L.H.
        • Nieminen M.S.
        • Omvik P.
        • Oparil S.
        • Wedel H.
        The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
        Am J Hypertens. 1997; 10: 705-713
        • Davis B.R.
        • Cutler J.A.
        • Gordon D.J.
        • Furberg C.D.
        • Wright Jr., J.T.
        • Cushman W.C.
        • Grimm R.H.
        • LaRosa J.
        • Whelton P.K.
        • Perry H.M.
        • Alderman M.H.
        • Ford C.E.
        • Oparil S.
        • Francis C.
        • Proschan M.
        • Pressel S.
        • Black H.R.
        • Hawkins C.M.
        Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
        Am J Hypertens. 1996; 9: 342-360